413
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Can Microbiota Research Change Our Understanding of Neurodegenerative diseases?

Pages 81-85 | Received 15 Dec 2015, Accepted 07 Jan 2016, Published online: 01 Apr 2016

References

  • Qin J , LiR, RaesJet al. A human gut microbial gene catalogue established by metagenomic sequencing . Nature464 ( 7285 ), 59 – 65 ( 2010 ).
  • Baquero F , NombelaC . The microbiome as a human organ . Clin. Microbiol. Infect.18 ( Suppl. 4 ), 2 – 4 ( 2012 ).
  • Lederberg J , McCrayAT . ‘Ome SweetOmics – a genealogical treasury of words . Scientist15 ( 7 ), 8 ( 2001 ).
  • Human Microbiome Project Consortium . Structure, function and diversity of the healthy human microbiome . Nature486 ( 7402 ), 207 – 214 ( 2012 ).
  • Maheshwari P , EslickGD . Bacterial infection and Alzheimer’s disease: a meta-analysis . J. Alzheimers Dis.43 ( 3 ), 957 – 966 ( 2015 ).
  • Agostini S , ClericiM, MancusoR . How plausible is a link between HSV-1 infection and Alzheimer’s disease?Expert Rev. Anti Infect. Ther.12 ( 3 ), 275 – 278 ( 2014 ).
  • Alonso R , PisaD, MarinaAI, MoratoE, RabanoA, CarrascoL . Fungal infection in patients with Alzheimer’s disease . J. Alzheimers Dis.41 ( 1 ), 301 – 311 ( 2014 ).
  • Alonso R , PisaD, MarinaAIet al. Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis . Int. J. Biol. Sci.11 ( 5 ), 546 – 558 ( 2015 ).
  • Dobbs SM , DobbsRJ, WellerC, CharlettA . Link between Helicobacter pylori infection and idiopathic Parkinsonism . Med. Hypotheses55 ( 2 ), 93 – 98 ( 2000 ).
  • Banack SA , CallerTA, StommelEW . The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis . Toxins (Basel)2 ( 12 ), 2837 – 2850 ( 2010 ).
  • Lim SL , Rodriguez-OrtizCJ, KitazawaM . Infection, systemic inflammation, and Alzheimer’s disease . Microbes Infect.17 ( 8 ), 549 – 556 ( 2015 ).
  • Bu XL , WangX, XiangYet al. The association between infectious burden and Parkinson’s disease: a case–control study . Parkinsonism Relat. Disord.21 ( 8 ), 877 – 881 ( 2015 ).
  • Bravo JA , ForsytheP, ChewMVet al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve . Proc. Natl Acad. Sci. USA108 ( 38 ), 16050 – 16055 ( 2011 ).
  • Bercik P , DenouE, CollinsJet al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice . Gastroenterology141 ( 2 ), 599 – 609, 609.e1–3 ( 2011 ).
  • Berer K , MuesM, KoutrolosMet al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination . Nature479 ( 7374 ), 538 – 541 ( 2011 ).
  • Miyake S , KimS, SudaWet al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters . PLoS ONE10 ( 9 ), e0137429 ( 2015 ).
  • Yin J , LiaoSX, HeYet al. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack . J. Am. Heart Assoc.4 ( 11 ), e002699 ( 2015 ).
  • Hawkes CH , Del TrediciK, BraakH . Parkinson’s disease: a dual-hit hypothesis . Neuropathol. Appl. Neurobiol.33 ( 6 ), 599 – 614 ( 2007 ).
  • Fasano A , BoveF, GabrielliMet al. The role of small intestinal bacterial overgrowth in Parkinson’s disease . Mov. Disord.28 ( 9 ), 1241 – 1249 ( 2013 ).
  • Forsyth CB , ShannonKM, KordowerJHet al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease . PLoS ONE6 ( 12 ), e28032 ( 2011 ).
  • Scheperjans F , AhoV, PereiraPAet al. Gut microbiota are related to Parkinson’s disease and clinical phenotype . Mov. Disord.30 ( 3 ), 350 – 358 ( 2015 ).
  • Keshavarzian A , GreenSJ, EngenPAet al. Colonic bacterial composition in Parkinson’s disease . Mov. Disord.30 ( 10 ), 1351 – 1360 ( 2015 ).
  • Hasegawa S , GotoS, TsujiHet al. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson’s disease . PLoS ONE10 ( 11 ), e0142164 ( 2015 ).
  • Goldman SM , KamelF, RossGWet al. Peptidoglycan recognition protein genes and risk of Parkinson’s disease . Mov. Disord.29 ( 9 ), 1171 – 1180 ( 2014 ).
  • Lema Tome CM , TysonT, ReyNL, GrathwohlS, BritschgiM, BrundinP . Inflammation and alpha-synuclein’s prion-like behavior in Parkinson’s disease-is there a link?Mol. Neurobiol.47 ( 2 ), 561 – 574 ( 2013 ).
  • Friedland RP . Mechanisms of molecular mimicry involving the microbiota in neurodegeneration . J. Alzheimers Dis.45 ( 2 ), 349 – 362 ( 2015 ).
  • Hill JM , LukiwWJ . Microbial-generated amyloids and Alzheimer’s disease (AD) . Front. Aging Neurosci.7, 9 ( 2015 ).
  • Scheperjans F , PekkonenE, KaakkolaS, AuvinenP . Linking smoking, coffee, urate, and Parkinson’s disease – a role for gut microbiota?J. Parkinsons Dis.5 ( 2 ), 255 – 262 ( 2015 ).
  • Kamer AR , CraigRG, PirragliaEet al. TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer’s disease patients and normal subjects . J. Neuroimmunol.216 ( 1 ), 92 – 97 ( 2009 ).
  • Noble JM , ScarmeasN, CelentiRSet al. Serum IgG antibody levels to periodontal microbiota are associated with incident Alzheimer disease . PLoS ONE9 ( 12 ), e114959 ( 2014 ).
  • Cockburn AF , DehlinJM, NganTet al. High throughput DNA sequencing to detect differences in the subgingival plaque microbiome in elderly subjects with and without dementia . Investig. Genet.3 ( 1 ), 19 ( 2012 ).
  • Harach T , MarungruangN, DutilleulNet al. Reduction of Alzheimer’s disease beta-amyloid pathology in the absence of gut microbiota . arXiv:1509.02273v2 [q-bio.MN] ( 2015 ).
  • Wu S , YiJ, ZhangYG, ZhouJ, SunJ . Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model . Physiol. Rep.3 ( 4 ), e12356 ( 2015 ).
  • van Nood E , VriezeA, NieuwdorpMet al. Duodenal infusion of donor feces for recurrent Clostridium difficile . N. Engl. J. Med.368 ( 5 ), 407 – 415 ( 2013 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.